Australian Pharma Stock News

In August 2026, SiTration and BHP announced two pilot deployments at BHP’s Copper Cities site in Arizona to test SiTration’s chemical-free, low-waste technology for producing copper from legacy mining water, including a larger trial targeting up to two tonnes of commercial-scale copper cathodes over two months. The collaboration highlights how reprocessing legacy mining water using lower-energy, filtration-and-electro-extraction techniques could open new sources of critical minerals while...

Catalyst Metals Limited recently reported its full-year results for the 12 months to June 30, 2026, with sales rising to A$631.94 million from A$361.41 million and net income increasing to A$171.12 million from A$119.27 million a year earlier. Earnings quality also strengthened, with basic earnings per share from continuing operations moving to A$0.6625 from A$0.4048, indicating improved profitability per share. Next, we’ll examine how this sharp uplift in annual sales and profitability...

What the latest Megaport earnings and guidance mean for investors Megaport (ASX:MP1) has drawn fresh attention after releasing full year 2026 results alongside new revenue guidance for fiscal 2027. This gives investors updated data on growth, profitability and future expectations. The company reported full year sales of A$312.19 million for the period ended 30 June 2026, compared with A$227.06 million a year earlier. Management also outlined an expected revenue range of A$620 million to A$730...

As the Australian market faces a cautious opening with the S&P/ASX 200 expected to dip, largely influenced by geopolitical tensions in the Middle East and rising oil prices, investors are closely monitoring how these developments might affect inflation and interest rates. In this environment, dividend stocks can offer a degree of stability and income potential; identifying those with strong fundamentals and reliable payout histories is key amidst such global uncertainties.

Amidst a backdrop of geopolitical tensions in the Middle East and fluctuating oil prices, the Australian market is experiencing volatility, with the S&P/ASX 200 expected to open lower following Wall Street's decline. In such uncertain times, identifying growth companies with high insider ownership can offer insights into potential resilience and confidence within those businesses.

As geopolitical tensions in the Middle East contribute to volatility in global markets, the Australian Stock Exchange (ASX) is feeling the impact with a cautious start, influenced by fluctuating oil prices and broader economic concerns. In such uncertain times, identifying undervalued stocks can offer potential opportunities for investors seeking resilience amidst market fluctuations.

The Australian market is poised for a cautious start, with the S&P/ASX 200 expected to open lower following Wall Street's downturn amid rising oil prices and geopolitical tensions in the Middle East. In such uncertain times, investors often look beyond established giants to explore opportunities in lesser-known areas of the market. Penny stocks, though sometimes perceived as relics of past trading days, can still offer intriguing prospects when backed by robust financials. These smaller or...

Silex Systems Limited recently reported its full-year results for the period ended June 30, 2026, with sales of A$13.71 million compared with A$7.27 million a year earlier and a reduced net loss of A$38.62 million versus A$42.56 million. The narrowing basic loss per share from A$0.179 to A$0.142 highlights improving operating performance even as the company remains loss-making. Next, we’ll examine how this revenue growth and smaller loss shape Silex Systems’ investment narrative and what it...

Elevra Lithium Limited recently reported full-year results to June 30, 2026, with sales rising to US$201.68 million and net income of US$43.07 million, alongside a shift from loss per share to positive earnings per share on both a basic and diluted basis. In parallel, Elevra Lithium secured a seven-year, market-linked spodumene supply agreement with Mangrove Lithium that includes a floor price above expected production costs and avoids ocean freight to international customers, reshaping the...

Codan (ASX:CDA) has drawn fresh attention after reporting full year 2026 sales of A$874.97m and net income of A$175.18m, alongside new revenue growth guidance for fiscal 2027. Codan's recent earnings update and 2027 revenue guidance have come alongside a strong share price run, with a 30 day share price return of 19.19% and a year to date share price return of 64.61%, while the 3 year total shareholder return of more than 5x hints at momentum that has been building rather than fading. Compare...

NRW Holdings (ASX:NWH) has drawn investor attention after reporting full year 2026 results, issuing revenue guidance for fiscal 2027, and lifting its ordinary franked dividend, all announced on 19 August 2026. The latest earnings, revenue guidance and higher franked dividend have come alongside strong share price momentum for NRW Holdings, with the stock delivering a 53.33% year to date share price return and a 1 year total shareholder return of 100.81%. This points to growing investor...

Vault Minerals earnings event and why it matters now Vault Minerals (ASX:VAU) released full year results to June 30, 2026, with sales of A$1,926.61 million and net income of A$278.41 million, supported by higher earnings per share. For investors tracking operational progress, these earnings provide an updated view of how the company is converting its Australian and Canadian mine portfolio into revenue, profit and per share outcomes during 2026. Vault Minerals shares closed at A$6.75, with a...

Why Neuren Pharmaceuticals stock is in focus now Neuren Pharmaceuticals (ASX:NEU) has caught investor attention after reporting half year 2026 results showing higher sales and revenue, a lower net profit figure, and the declaration of a fully franked interim dividend. Neuren Pharmaceuticals shares trade at A$19.89, with a 90 day share price return of 46.36% and a 30 day share price return of 10.50%. This comes despite a 7 day share price pullback of 11.72%, while the 5 year total shareholder...

In August 2026, Zip Co Limited (ASX:ZIP) reported full-year 2026 results showing higher revenue of A$1,336 million and net income of A$116.38 million, and the Board also approved a share repurchase program of up to 79,680,755 shares, or 6.4% of issued capital, for A$50 million running through September 14, 2027. Together, the stronger earnings and intention to reduce the A$1.25 billion share count via buybacks highlight management’s focus on profitability and capital return. We’ll now...

Smartgroup Corporation Ltd has reported its half-year 2026 results, with sales of A$179.49 million and net income of A$42.36 million, and declared a A$0.215 per-share dividend for the six months to 30 June 2026, paid on 23 September 2026. The combination of higher sales, improved earnings per share and a cash dividend signals management’s confidence in the business’s cash generation and balance sheet strength. We’ll now examine how Smartgroup’s higher half-year earnings and new dividend...

Redox earnings, dividend and acquisition plans come into focus Redox (ASX:RDX) is back on investor radar after its full year 2026 results, an affirmed fully franked dividend and fresh comments that the company is actively assessing acquisition opportunities. The latest update gives you a clearer picture of how Redox is using its balance sheet and cash position. It also shows how management is thinking about capital allocation between shareholder distributions and potential deals. At a latest...

Guzman y Gomez Limited recently reported full-year 2026 results showing sales of A$520.4 million and a net loss of A$26.7 million, while also announcing both a fully franked ordinary dividend of A$0.262 per share and a fully franked special dividend of A$0.144 per share, payable on 30 September 2026. At the same time, the company outlined plans to open 35 new Australian restaurants in Fiscal Year 2027, with the incremental fourth-quarter openings expected to have only a limited impact on...

Betmakers Technology Group went into this result with the stock at A$0.21, up strongly over the past month but softer in the last week. That price move suggests optimism has been building. The numbers now force a sharper focus on the main strain in the story. The company is still loss making on a trailing basis, with earnings from continuing operations of A$5.2 million in the red. The headline this time is simple. Revenue in the wagering technology business is holding near A$92.6 million, yet...

Liontown Limited recently reported full-year 2026 results showing sales of A$639.14 million, up from A$297.57 million a year earlier, and net income of A$92.55 million versus a net loss of A$193.28 million, marking a shift to positive earnings per share. Alongside record revenue, the company highlighted its first positive underlying NPAT and a strengthened balance sheet with A$561 million in cash and no net gearing, underlining materially improved financial resilience. We’ll now examine how...

TerraCom’s share price closed at A$0.069 after a weak week for the stock, yet the real story sits in the earnings hit to profitability. The headline is simple. Revenue in the latest half stayed in the tens of millions, but the company still posted a net loss of over A$30 million and remained unprofitable over the past year. The market is treating TerraCom like a distressed asset on a cheap P/S multiple. The key question now is whether that discount reflects the ongoing loss profile or whether...

Grange Resources came into this result as a deeply out of favour iron ore producer, with the stock down roughly 16% over the past three months and trading on a low P/S multiple. The headline from this half is a brutal profit squeeze. Revenue for H1 2026 was A$230.8m, while the company reported a net loss of A$541.8m and basic earnings per share loss of A$0.47. The share price finished at A$0.135 after the release, which leaves investors weighing a harsh earnings reset against an already...

Why BWP Trust’s latest full year earnings matter for investors BWP Trust (ASX:BWP) recently released full year results to 30 June 2026, reporting sales of A$209.33 million and net income of A$408.4 million. Basic earnings per share from continuing operations were A$0.559. The full year earnings release comes after a weaker run in BWP Trust’s share price, with the stock down 6.2% over the past month and 7.6% year to date. Total shareholder return over five years is 14.6%, pointing to steadier...

Star Entertainment Group went into this result priced like a deeply wounded turnaround story, with the stock closing at A$0.125 and trading on a low price to sales multiple against Australian hospitality peers. The headline from the earnings is not revenue, which sits around A$1.3b over the last twelve months. The story is the persistent losses, with earnings from continuing operations running into the hundreds of millions in the red and recent shareholder dilution still fresh in investors...

Orthocell stock came into the FY 2026 result under pressure, down over the past week even after a modest 30 day gain, as investors weighed a rich valuation for an unprofitable biotech. The headline from this earnings release is not the top line. It is the size of the loss investors are still being asked to carry. Management reported trailing twelve month revenue of A$11.4m, yet a loss from continuing operations of A$13.9m. For a stock trading on a P/S ratio above both its industry and peer...